Location History:
- New York, NY (US) (2012)
- Bloomfield, NJ (US) (2021)
Company Filing History:
Years Active: 2012-2021
Title: Bi-Sen Ding: Innovator in Recombinant Therapeutics
Introduction
Bi-Sen Ding is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of recombinant therapeutics. His innovative work focuses on developing fusion proteins that target circulating red blood cells, which has the potential to revolutionize treatments for various medical conditions.
Latest Patents
Bi-Sen Ding holds a patent for "Targeting recombinant therapeutics to circulating red blood cells." This patent describes fusion proteins comprising a single chain antigen-binding domain (scFv) of a monoclonal antibody, linked to an anti-thrombotic agent, anti-inflammatory agent, or a pro-drug thereof. The polypeptide binds to a binding site expressed on the surface of a red blood cell at a density greater than 5,000 copies per red blood cell. The patent also covers pharmaceutical compositions comprising these fusion proteins and methods for delivering an anti-thrombotic agent to the surface of a red blood cell. Furthermore, it outlines methods for treating or preventing thrombosis, tissue ischemia, acute myocardial infarction (AMI), ischemic stroke, cerebrovascular disease, pulmonary embolism, or ischemic peripheral vascular disease through the administration of these fusion proteins or compositions.
Career Highlights
Bi-Sen Ding is affiliated with the University of Pennsylvania, where he continues to advance his research in the field of therapeutics. His work has garnered attention for its potential applications in treating serious health conditions, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Bi-Sen Ding has collaborated with notable researchers in his field, including Vladimir R Muzykantov and Sergei V Zaitsev. These collaborations have contributed to the development and refinement of his innovative therapeutic approaches.
Conclusion
Bi-Sen Ding's work in recombinant therapeutics exemplifies the impact of innovation in medicine. His patented technologies hold promise for enhancing treatment options for various diseases, marking him as a significant figure in the field of medical research.